{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:17:00Z","timestamp":1793888220512,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67213-6","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:48:10Z","timestamp":1765302490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An outer membrane vesicle vaccine prevents lung pathology in a macaque model of pneumonic melioidosis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0177-8135","authenticated-orcid":false,"given":"Sarah M.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4331-3683","authenticated-orcid":false,"given":"Erik W.","family":"Settles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly R.","family":"Celona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7601-253X","authenticated-orcid":false,"given":"Austin B.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christpher","family":"Davitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalen","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael R.","family":"de Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5540-1256","authenticated-orcid":false,"given":"Anthony E.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Woerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8878-8837","authenticated-orcid":false,"given":"Bart J.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Wimley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7741-391X","authenticated-orcid":false,"given":"James B.","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinh T.","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1256-6410","authenticated-orcid":false,"given":"Derek","family":"Pociask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0089-5820","authenticated-orcid":false,"given":"Paul","family":"Keim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3719-0779","authenticated-orcid":false,"given":"Kasi","family":"Russell-Lodrigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1710-6974","authenticated-orcid":false,"given":"Chad J.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4799-4941","authenticated-orcid":false,"given":"Lisa A.","family":"Morici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"67213_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2015.8","volume":"1","author":"D Limmathurotsakul","year":"2016","unstructured":"Limmathurotsakul, D. et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat. Microbiol. 1, 15008 (2016).","journal-title":"Nat. Microbiol."},{"key":"67213_CR2","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMoa2306448","volume":"389","author":"JK Petras","year":"2023","unstructured":"Petras, J. K. et al. Locally Acquired Melioidosis Linked to Environment - Mississippi, 2020-2023. N. Engl. J. Med. 389, 2355\u20132362 (2023).","journal-title":"N. Engl. J. Med."},{"key":"67213_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa2116130","volume":"386","author":"JE Gee","year":"2022","unstructured":"Gee, J. E. et al. Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray. N. Engl. J. Med. 386, 861\u2013868 (2022).","journal-title":"N. Engl. J. Med."},{"key":"67213_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.107","volume":"4","author":"WJ Wiersinga","year":"2018","unstructured":"Wiersinga, W. J. et al. Melioidosis. Nat. Rev. Dis. Primers 4, 17107 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"67213_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4269\/ajtmh.24-0007","volume":"111","author":"M Howes","year":"2024","unstructured":"Howes, M. & Currie, B. J. Melioidosis and activation from latency: The \u201cTime Bomb\u201d has not occurred. Am. J. Trop. Med. Hygiene 111, 156\u2013160 (2024).","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"67213_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.coviro.2012.01.004","volume":"2","author":"DL Burns","year":"2012","unstructured":"Burns, D. L. Licensure of vaccines using the Animal Rule. Curr. Opin. Virol. 2, 353\u2013356 (2012).","journal-title":"Curr. Opin. Virol."},{"key":"67213_CR7","unstructured":"Food and Drug Administration. Product Development Under the Animal Rule. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/product-development-under-animal-rule (2015)."},{"key":"67213_CR8","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1016\/j.vaccine.2011.08.058","volume":"29","author":"W Nieves","year":"2011","unstructured":"Nieves, W. et al. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine 29, 8381\u20138389 (2011).","journal-title":"Vaccine"},{"key":"67213_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CVI.00119-14","volume":"21","author":"W Nieves","year":"2014","unstructured":"Nieves, W. et al. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis. Clin. Vaccine Immunol. 21, 747\u2013754 (2014).","journal-title":"Clin. Vaccine Immunol."},{"key":"67213_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-021-00281-z","volume":"6","author":"SM Baker","year":"2021","unstructured":"Baker, S. M. et al. Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine. NPJ Vaccines 6, 1\u201310 (2021).","journal-title":"NPJ Vaccines"},{"key":"67213_CR11","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.bbamcr.2013.12.011","volume":"1843","author":"KE Bonnington","year":"2014","unstructured":"Bonnington, K. E. & Kuehn, M. J. Protein selection and export via outer membrane vesicles. Biochim. Biophys. Acta Mol. Cell Res. 1843, 1612\u20131619 (2014).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"67213_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/14760584.2023.2222015","volume":"22","author":"GS Marshall","year":"2023","unstructured":"Marshall, G. S. et al. A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB). Exp. Rev Vaccines 22, 530\u2013544 (2023).","journal-title":"Exp. Rev Vaccines"},{"key":"67213_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/vaccines5040049","volume":"5","author":"SM Baker","year":"2017","unstructured":"Baker, S. M. et al. A Burkholderia pseudomallei outer membrane vesicle vaccine provides cross protection against inhalational glanders in mice and non-human primates. Vaccines 5, 49 (2017).","journal-title":"Vaccines"},{"key":"67213_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4269\/ajtmh.15-0262","volume":"94","author":"RR Hemme","year":"2016","unstructured":"Hemme, R. R. et al. Serological evidence of infection with endemic human pathogens among free-ranging old world monkeys in puerto rico. Am. J. Trop. Med. Hyg. 94, 1095\u20131099 (2016).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"67213_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.7589\/0090-3558-6.4.211","volume":"6","author":"AF Kaufmann","year":"1970","unstructured":"Kaufmann, A. F. et al. Melioidosis in imported non-human primates. J. Wildl. Dis. 6, 211\u2013219 (1970).","journal-title":"J. Wildl. Dis."},{"key":"67213_CR16","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1111\/tbed.12315","volume":"63","author":"T Kasantikul","year":"2016","unstructured":"Kasantikul, T. et al. Retrospective study on fatal melioidosis in Captive zoo animals in Thailand. Transbound Emerg. Dis. 63, e389\u2013e394 (2016).","journal-title":"Transbound Emerg. Dis."},{"key":"67213_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1258\/002367786780808749","volume":"20","author":"PE Fritz","year":"1986","unstructured":"Fritz, P. E., Miller, J. G., Slayter, M. & Smith, T. J. Naturally occurring melioidosis in a colonized rhesus monkey (Macaca mulatta). Lab Anim. 20, 281\u2013285 (1986).","journal-title":"Lab Anim."},{"key":"67213_CR18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4269\/ajtmh.15-0114","volume":"93","author":"V Suttisunhakul","year":"2015","unstructured":"Suttisunhakul, V. et al. Evaluation of polysaccharide-based latex agglutination assays for the rapid detection of antibodies to Burkholderia pseudomallei. Am. J. Trop. Med. Hygiene 93, 542\u2013546 (2015).","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"67213_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/026119290903701S05","volume":"37","author":"RG Higbee","year":"2009","unstructured":"Higbee, R. G. et al. An immunologic model for rapid vaccine assessment \u2014 a clinical trial in a test tube. Altern. Lab. Anim. 37, 19\u201327 (2009).","journal-title":"Altern. Lab. Anim."},{"key":"67213_CR20","doi-asserted-by":"publisher","first-page":"13499","DOI":"10.1073\/pnas.0812080106","volume":"106","author":"PL Felgner","year":"2009","unstructured":"Felgner, P. L. et al. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc. Natl. Acad. Sci. USA 106, 13499\u201313504 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67213_CR21","doi-asserted-by":"publisher","first-page":"e0011072","DOI":"10.1371\/journal.pntd.0011072","volume":"17","author":"EW Settles","year":"2023","unstructured":"Settles, E. W. et al. Development and evaluation of a multiplex serodiagnostic bead assay (BurkPx) for accurate melioidosis diagnosis. PLoS Negl. Trop. Dis. 17, e0011072 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"67213_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/cei.13286","volume":"196","author":"L Morici","year":"2019","unstructured":"Morici, L., Torres, A. G. & Titball, R. W. Novel multi-component vaccine approaches for Burkholderia pseudomallei. Clin. Exp. Immunol. 196, 178\u2013188 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"67213_CR23","doi-asserted-by":"publisher","DOI":"10.3201\/eid2106.141480","volume":"21","author":"D Limmathurotsakul","year":"2015","unstructured":"Limmathurotsakul, D. et al. Consensus on the development of vaccines against naturally acquired melioidosis. Emerg. Infect. Dis. 21, e141480 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"67213_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/14760584.2020.1791089","volume":"19","author":"N Khakhum","year":"2020","unstructured":"Khakhum, N., Chapartegui-Gonz\u00e1lez, I. & Torres, A. G. Combating the great mimicker: latest progress in the development of Burkholderia pseudomallei vaccines. Expert Rev. Vaccines 19, 653\u2013660 (2020).","journal-title":"Expert Rev. Vaccines"},{"key":"67213_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/QCO.0000000000000869","volume":"35","author":"BJ Currie","year":"2022","unstructured":"Currie, B. J. Melioidosis and Burkholderia pseudomallei: progress in epidemiology, diagnosis, treatment and vaccination. Curr. Opin. Infect. Dis. 35, 517\u2013523 (2022).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"67213_CR26","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/pathogens10111353","volume":"10","author":"I Chapartegui-Gonz\u00e1lez","year":"2021","unstructured":"Chapartegui-Gonz\u00e1lez, I., Bowser, S., Torres, A. G. & Khakhum, N. Recent Progress in Shigella and Burkholderia pseudomallei vaccines. Pathogens 10, 1353 (2021).","journal-title":"Pathogens"},{"key":"67213_CR27","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1128\/iai.65.9.3648-3653.1997","volume":"65","author":"M Ho","year":"1997","unstructured":"Ho, M. et al. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect. Immun. 65, 3648\u20133653 (1997).","journal-title":"Infect. Immun."},{"key":"67213_CR28","doi-asserted-by":"publisher","first-page":"e0004152","DOI":"10.1371\/journal.pntd.0004152","volume":"9","author":"K Jenjaroen","year":"2015","unstructured":"Jenjaroen, K. et al. T-Cell Responses are associated with survival in acute melioidosis patients. PLOS Negl. Trop. Dis. 9, e0004152 (2015).","journal-title":"PLOS Negl. Trop. Dis."},{"key":"67213_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3201\/eid2603.190206","volume":"26","author":"P Rongkard","year":"2020","unstructured":"Rongkard, P. et al. Human immune responses to melioidosis and cross-reactivity to low-virulence Burkholderia species, Thailand1. Emerg. Infect. Dis. 26, 463\u2013471 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"67213_CR30","doi-asserted-by":"publisher","first-page":"e0006287","DOI":"10.1371\/journal.pntd.0006287","volume":"12","author":"S Sengyee","year":"2018","unstructured":"Sengyee, S. et al. Comprehensive analysis of clinical Burkholderia pseudomallei isolates demonstrates conservation of unique lipid A structure and TLR4-dependent innate immune activation. PLoS Negl. Trop. Dis. 12, e0006287 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"67213_CR31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1086\/520441","volume":"29","author":"C Charuchaimontri","year":"1999","unstructured":"Charuchaimontri, C. et al. Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin. Infect. Dis. 29, 813\u2013818 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"67213_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/IAI.70.2.504-511.2002","volume":"70","author":"B Liu","year":"2002","unstructured":"Liu, B., Koo, G. C., Yap, E. H., Chua, K. L. & Gan, Y.-H. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect. Immun. 70, 504\u2013511 (2002).","journal-title":"Infect. Immun."},{"key":"67213_CR33","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.1016\/j.vaccine.2011.05.009","volume":"29","author":"A Henderson","year":"2011","unstructured":"Henderson, A., Propst, K., Kedl, R. & Dow, S. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity. Vaccine 29, 5304\u20135312 (2011).","journal-title":"Vaccine"},{"key":"67213_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00019-24","volume":"92","author":"N Khakhum","year":"2024","unstructured":"Khakhum, N. et al. Decoration of Burkholderia Hcp1 protein to virus-like particles as a vaccine delivery platform. Infect Immun 92, e0001924 (2024).","journal-title":"Infect Immun"},{"key":"67213_CR35","doi-asserted-by":"publisher","first-page":"e6496","DOI":"10.1371\/journal.pone.0006496","volume":"4","author":"Y Hara","year":"2009","unstructured":"Hara, Y., Mohamed, R. & Nathan, S. Immunogenic Burkholderia pseudomallei Outer Membrane Proteins as Potential Candidate Vaccine Targets. PLOS ONE 4, e6496 (2009).","journal-title":"PLOS ONE"},{"key":"67213_CR36","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1128\/iai.59.7.2252-2258.1991","volume":"59","author":"JN Weiser","year":"1991","unstructured":"Weiser, J. N. & Gotschlich, E. C. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect. Immun. 59, 2252\u20132258 (1991).","journal-title":"Infect. Immun."},{"key":"67213_CR37","doi-asserted-by":"publisher","first-page":"A23","DOI":"10.1016\/S0264-410X(02)00383-3","volume":"20","author":"P Jeannin","year":"2002","unstructured":"Jeannin, P. et al. Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine 20, A23\u2013A27 (2002).","journal-title":"Vaccine"},{"key":"67213_CR38","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.4049\/jimmunol.1202221","volume":"190","author":"P Bacher","year":"2013","unstructured":"Bacher, P. et al. Antigen-reactive T cell enrichment for direct, high-resolution analysis of the human naive and memory Th cell repertoire. J. Immunol. 190, 3967\u20133976 (2013).","journal-title":"J. Immunol."},{"key":"67213_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/cid\/cir808","volume":"54","author":"EM Meumann","year":"2012","unstructured":"Meumann, E. M., Cheng, A. C., Ward, L. & Currie, B. J. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin. Infect. Dis. 54, 362\u2013369 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"67213_CR40","doi-asserted-by":"crossref","unstructured":"Meumann, E. M., Limmathurotsakul, D., Dunachie, S. J., Wiersinga, W. J. & Currie, B. J. Burkholderia pseudomallei and melioidosis. Nat. Rev. Microbiol. 22, 155\u2013169 (2024).","DOI":"10.1038\/s41579-023-00972-5"},{"key":"67213_CR41","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S1473-3099(21)00022-0","volume":"21","author":"BJ Currie","year":"2021","unstructured":"Currie, B. J. et al. The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation. Lancet Infect. Dis. 21, 1737\u20131746 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"67213_CR42","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1128\/IAI.01313-09","volume":"78","author":"KL Propst","year":"2010","unstructured":"Propst, K. L., Mima, T., Choi, K.-H., Dow, S. W. & Schweizer, H. P. A Burkholderia pseudomallei \u0394purM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists. Infect. Immun. 78, 3136\u20133143 (2010).","journal-title":"Infect. Immun."},{"key":"67213_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.provac.2014.07.007","volume":"8","author":"H Petersen","year":"2014","unstructured":"Petersen, H., Nieves, W., Russell-Lodrigue, K., Roy, C. J. & Morici, L. A. Evaluation of a Burkholderia pseudomallei outer membrane vesicle vaccine in Nonhuman primates. Procedia Vaccinol. 8, 38\u201342 (2014).","journal-title":"Procedia Vaccinol."},{"key":"67213_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.vascn.2003.07.001","volume":"49","author":"JM Hartings","year":"2004","unstructured":"Hartings, J. M. & Roy, C. J. The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. J. Pharmacol. Toxicol. Methods 49, 39\u201355 (2004).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"67213_CR45","doi-asserted-by":"publisher","first-page":"e0289619","DOI":"10.1371\/journal.pone.0289619","volume":"18","author":"K Hristova","year":"2023","unstructured":"Hristova, K. & Wimley, W. C. Determining the statistical significance of the difference between arbitrary curves: A spreadsheet method. PLOS ONE 18, e0289619 (2023).","journal-title":"PLOS ONE"},{"key":"67213_CR46","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1016\/j.vaccine.2017.03.099","volume":"35","author":"A Dauner","year":"2017","unstructured":"Dauner, A. et al. The in vitro MIMIC\u00ae platform reflects age-associated changes in immunological responses after influenza vaccination. Vaccine 35, 5487\u20135494 (2017).","journal-title":"Vaccine"},{"key":"67213_CR47","doi-asserted-by":"publisher","first-page":"e3040","DOI":"10.1371\/journal.pntd.0003040","volume":"8","author":"Y Fujii","year":"2014","unstructured":"Fujii, Y. et al. Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models. PLoS Negl. Trop. Dis. 8, e3040 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"67213_CR48","doi-asserted-by":"publisher","first-page":"e0006851","DOI":"10.1371\/journal.pntd.0006851","volume":"13","author":"J Yi","year":"2019","unstructured":"Yi, J. et al. Caprine humoral response to Burkholderia pseudomallei antigens during acute melioidosis from aerosol exposure. PLoS Negl. Trop. Dis. 13, e0006851 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"67213_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jim.2005.11.019","volume":"309","author":"SA Schlottmann","year":"2006","unstructured":"Schlottmann, S. A., Jain, N., Chirmule, N. & Esser, M. T. A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheres. J. Immunol. Methods 309, 75\u201385 (2006).","journal-title":"J. Immunol. Methods"},{"key":"67213_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00136-11","volume":"2","author":"DE Nuti","year":"2011","unstructured":"Nuti, D. E. et al. Identification of circulating bacterial antigens by in vivo microbial antigen discovery. mBio 2, e00136-11 (2011).","journal-title":"mBio"},{"key":"67213_CR51","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4269\/ajtmh.16-0308","volume":"96","author":"T Nualnoi","year":"2017","unstructured":"Nualnoi, T. et al. Development of Immunoassays for Burkholderia pseudomallei Typical and Atypical Lipopolysaccharide Strain Typing. Am. J. Trop. Med. Hyg. 96, 358\u2013367 (2017).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"67213_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2180-6-61","volume":"6","author":"EA Vander Top","year":"2006","unstructured":"Vander Top, E. A., Perry, G. A. & Gentry-Nielsen, M. J. A novel flow cytometric assay for measurement of in vivo pulmonary neutrophil phagocytosis. BMC Microbiol. 6, 61 (2006).","journal-title":"BMC Microbiol."},{"key":"67213_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00333-4","volume":"6","author":"N Khakhum","year":"2021","unstructured":"Khakhum, N., Bharaj, P., Walker, D. H., Torres, A. G. & Endsley, J. J. Antigen-specific antibody and polyfunctional T cells generated by respiratory immunization with protective Burkholderia \u0394tonB \u0394hcp1 live attenuated vaccines. NPJ Vaccines 6, 72 (2021).","journal-title":"NPJ Vaccines"},{"key":"67213_CR54","doi-asserted-by":"crossref","unstructured":"Kusters, M. A. A. et al. Functionality of the pneumococcal antibody response in Down syndrome subjects. Vaccine 31, 6261\u20136265 (2013).","DOI":"10.1016\/j.vaccine.2013.09.070"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67213-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:07:25Z","timestamp":1768403245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67213-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67213"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67213-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.B.M. and L.A.M. are inventors of the O.M.V. vaccine and have a U.S. Provisional Application No.: 63\/554,522 filed. H. Yoon, C. Dao, and J. Moser are\/were Sanofi employees and may hold shares and\/or stock options in the company. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"519"}}